CMS Plans Advance Care Planning Quality Measure

Why It Matters

Linking payment to ACP incentivizes early, patient‑centered discussions, potentially lowering wasteful spending while aligning care with patient preferences.

Key Takeaways

• CMS links reimbursement to documented advance care planning
• Measure covers hospitals, home health, SNFs, and surgery centers
• Only 36% of adults have recorded end‑of‑life wishes
• Potential $200 B annual savings from avoided unwanted care
• Implementation concerns focus on avoiding check‑box compliance

Pulse Analysis

Advance care planning has emerged as a cornerstone of value‑based care, yet the United States still lags in documented patient preferences. By embedding an ACP quality metric into the MIPS framework, CMS aims to standardize conversations across a broad spectrum of care settings. This move reflects a growing consensus that early, documented discussions can steer patients toward appropriate hospice and palliative services, reducing the reliance on costly, intensive interventions at the end of life.

Financial analysts estimate that up to $200 billion is spent annually on treatments patients would decline if their wishes were known. The proposed measure could unlock significant savings by prompting providers to capture and honor these preferences well before a crisis. For technology firms like Koda Health, the policy creates a market for robust electronic health‑record integration tools that ensure high‑quality ACP documentation, potentially accelerating adoption of digital advance directive platforms.

However, the success of the measure hinges on its design. Critics warn that a simplistic “checkbox” approach may generate superficial compliance without meaningful patient engagement. Stakeholders such as the National Alliance for Care at Home highlight gaps in payment mechanisms for home‑health agencies, risking uneven implementation. As CMS refines the metric’s documentation standards—emphasizing values, surrogate designation, and continuity of understanding—the industry will watch closely to see whether the policy translates into genuine improvements in end‑of‑life care quality.